Product Information
TIKOSYN 500 MCG CAPSULE is a brand product labeled by Pfizer Inc., priced at $10.7711 per EA under NDC 00069582061. Its NADAC has been published 485 times since Aug 3, 2016.
FDA first approved this application on Oct 1, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the dofetilide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/1
Manufacturer
Pfizer Inc.NDC
00069582061
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
1/1/2025
Active Ingredients
DOFETILIDEApproval Type
New Drug (NDA)
FDA Application
NDA020931FDA Approved
10/1/1999
TE Code
AB
On Market Since
10/1/1999
Pharmacological Classes
Price Statistics
The NADAC for TIKOSYN 500 MCG CAPSULE has been published 485 times since Aug 3, 2016, and over the history we have for it it has risen 40.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.7711 per EA |
|---|---|
| All-time high | $10.7711 (Nov 12, 2025) |
| All-time low | $7.0094 (Dec 21, 2016) |
| 52-week high | $10.7711 |
| 52-week low | $10.7711 |
| Median price | $10.0523 |
| Average price | $9.9975 |
| Largest weekly change | +16.6% (Dec 13, 2017) |
| Weeks tracked | 485 |
| Tracking since | Aug 3, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+2.0%
5Y
+7.2%
All
+40.1%
Last surveyed Nov 12, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIKOSYN 500 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIKOSYN 500 MCG CAPSULE, manufactured by Pfizer Inc., is $10.7711 per EA (NDC 00069582061), effective Nov 12, 2025.
How has the price of TIKOSYN 500 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIKOSYN 500 MCG CAPSULE has risen 40.1%. It has been tracked across 485 weekly CMS publications since Aug 3, 2016.
What are the highest and lowest recorded NADAC prices for TIKOSYN 500 MCG CAPSULE?
Since Aug 3, 2016, the NADAC for TIKOSYN 500 MCG CAPSULE has ranged from a low of $7.0094 (Dec 21, 2016) to a high of $10.7711 (Nov 12, 2025), with a median of $10.0523 per EA.
Are there cheaper alternatives to TIKOSYN 500 MCG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TIKOSYN 500 MCG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TIKOSYN 500 MCG CAPSULE?
TIKOSYN 500 MCG CAPSULE (NDC 00069582061) is labeled by Pfizer Inc., and CMS classifies it as a brand product.